Globally, the methodology used in this study consists of a detailed bioinformatic analysis that takes advantage of previously published data to observe them from a new perspective and has allowed the identification of some features and genes that may be relevant in the pathogenesis of ET in patients with CALR or JAK2 mutations. This evidence concerns the gene JAK2 and essential thrombocythemia.